These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38686236)

  • 1. The Rise of Remimazolam: A Review of Pharmacology, Clinical Efficacy, and Safety Profiles.
    Dessai S; Ninave S; Bele A
    Cureus; 2024 Mar; 16(3):e57260. PubMed ID: 38686236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive review of remimazolam for sedation.
    Noor N; Legendre R; Cloutet A; Chitneni A; Varrassi G; Kaye AD
    Health Psychol Res; 2021; 9(1):24514. PubMed ID: 34746482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychomotor Recovery Following Remimazolam-induced Sedation and the Effectiveness of Flumazenil as an Antidote.
    Chen X; Sang N; Song K; Zhong W; Wang H; Jiang J; Huang Y; Hu P
    Clin Ther; 2020 Apr; 42(4):614-624. PubMed ID: 32178858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remimazolam: its clinical pharmacology and evolving role in anesthesia and sedation practice.
    Masui K
    Curr Opin Anaesthesiol; 2024 Aug; 37(4):344-351. PubMed ID: 38841907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remimazolam: pharmacological characteristics and clinical applications in anesthesiology.
    Kim KM
    Anesth Pain Med (Seoul); 2022 Jan; 17(1):1-11. PubMed ID: 35139608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures.
    Rogers WK; McDowell TS
    IDrugs; 2010 Dec; 13(12):929-37. PubMed ID: 21154153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics.
    Antonik LJ; Goldwater DR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):274-83. PubMed ID: 22190555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remimazolam: An Updated Review of a New Sedative and Anaesthetic.
    Hu Q; Liu X; Wen C; Li D; Lei X
    Drug Des Devel Ther; 2022; 16():3957-3974. PubMed ID: 36411859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remimazolam: Non-Clinical and Clinical Profile of a New Sedative/Anesthetic Agent.
    Kilpatrick GJ
    Front Pharmacol; 2021; 12():690875. PubMed ID: 34354587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety Profile of Remimazolam for Sedation in Adults Undergoing Short Surgical Procedures.
    Morimoto Y
    Ther Clin Risk Manag; 2022; 18():95-100. PubMed ID: 35140469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remimazolam: Pharmacologic Considerations and Clinical Role in Anesthesiology.
    Wesolowski AM; Zaccagnino MP; Malapero RJ; Kaye AD; Urman RD
    Pharmacotherapy; 2016 Sep; 36(9):1021-7. PubMed ID: 27496519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remimazolam: The future of its sedative potential.
    Goudra BG; Singh PM
    Saudi J Anaesth; 2014 Jul; 8(3):388-91. PubMed ID: 25191193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of remimazolam and sedatives in the intensive care unit.
    Choi HR; Song IA
    Acute Crit Care; 2022 May; 37(2):151-158. PubMed ID: 35698764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary Experience With Remimazolam for Procedural Sedation and as an Adjunct to General Anesthesia During Diagnostic and Interventional Cardiac Procedures.
    Gillis H; McKee C; Chenault K; Corridore M; Tobias JD
    Cardiol Res; 2024 Feb; 15(1):12-17. PubMed ID: 38464705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remimazolam: A Novel Option for Procedural Sedation in High Risk Patients.
    Pantos MM; Kennedy DR; Nemec EC
    J Pharm Pract; 2023 Feb; 36(1):149-154. PubMed ID: 34155946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remimazolam for Sedation During Upper Gastrointestinal Endoscopy in an Adolescent.
    Garrett A; Flowers J; Ng V; Tobias JD
    J Med Cases; 2022 Oct; 13(10):495-498. PubMed ID: 36407860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics.
    Schüttler J; Eisenried A; Lerch M; Fechner J; Jeleazcov C; Ihmsen H
    Anesthesiology; 2020 Apr; 132(4):636-651. PubMed ID: 31972655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sedation outcomes for remimazolam, a new benzodiazepine.
    Oka S; Satomi H; Sekino R; Taguchi K; Kajiwara M; Oi Y; Kobayashi R
    J Oral Sci; 2021 Jun; 63(3):209-211. PubMed ID: 34092775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-to-Event Modeling for Remimazolam for the Indication of Induction and Maintenance of General Anesthesia.
    Lohmer LL; Schippers F; Petersen KU; Stoehr T; Schmith VD
    J Clin Pharmacol; 2020 Apr; 60(4):505-514. PubMed ID: 31989598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.